{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:42Z","timestamp":1786998462037,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ygyno.2016.04.028","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T14:38:12Z","timestamp":1462459092000},"page":"139-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease"],"prefix":"10.1016","volume":"142","clinical-trial-number":[{"clinical-trial-number":"nct02385188","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Renee A.","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destin R.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien N.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor J.","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.04.028_bb0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.det.2010.08.002","article-title":"Extramammary Paget's disease: summary of current knowledge","volume":"28","author":"Lam","year":"2010","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9378(99)70143-2","article-title":"Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision","volume":"180","author":"Fanning","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/gyno.2000.5741","article-title":"Paget's disease of the vulva: pathology, pattern of involvement, and prognosis","volume":"77","author":"Parker","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2006.09.017","article-title":"The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva","volume":"104","author":"Black","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3109\/01443610903191285","article-title":"The prospective management of women with newly diagnosed vulval intraepithelial neoplasia: clinical outcome and quality of life","volume":"29","author":"McFadden","year":"2009","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2015.07.097","article-title":"Effects of imiquimod on vulvar Paget's disease: a systematic review of literature","volume":"139","author":"Machida","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1067\/S0190-9622(03)02107-8","article-title":"Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream","volume":"49","author":"Wang","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0040","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1067\/mjd.2002.126584","article-title":"Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports","volume":"47","author":"Zampogna","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0045","article-title":"Interventions for the treatment of Paget's disease of the vulva","volume":"10","author":"Edey","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0050","first-page":"56","article-title":"Treatment of dysplastic nevi with 5% imiquimod cream, a pilot study","volume":"5","author":"Dusza","year":"2006","journal-title":"J Drugs Dermatol: JDD"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0055","author":"U.S. Department of Health and Human Services. FDA U.S. Food and Drug Administration. Highlights of Prescribing Information. Aldara\u00ae (imiquimod) Cream, 5%. Revised: October 2010 Accessed March 14"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0060","unstructured":"Pharmaceuticals, M. Product Information: Imiquimod(R), imiquimod 5% cream. 2004: St. Paul, MN."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0065","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/1097-0142(19800801)46:3<590::AID-CNCR2820460327>3.0.CO;2-Q","article-title":"Vulvar Paget's disease. A topographic study","volume":"46","author":"Gunn","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejso.2014.10.050","article-title":"Quality of life and sexual function after surgery in early stage vulvar cancer","volume":"41","author":"Forner","year":"2015","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1097-0142(197801)41:1<10::AID-CNCR2820410103>3.0.CO;2-G","article-title":"Treatment of recurrent Paget's disease of the vulva with topical bleomycin","volume":"41","author":"Watring","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0085","doi-asserted-by":"crossref","first-page":"1048.e1","DOI":"10.1016\/j.jaad.2010.08.034","article-title":"Topical use of systemic drugs in dermatology: a comprehensive review","volume":"65","author":"Chiu","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0090","first-page":"331","article-title":"Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: Response to topical 5-fluorouracil","volume":"65","author":"Del Castillo","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0095","first-page":"454","article-title":"Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil","volume":"66","author":"Brown","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.ygyno.2016.04.028_bb0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archderm.1971.04000210090018","article-title":"Triple extramammary Paget's disease","volume":"104","author":"Kawatsu","year":"1971","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0105","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/eji.201344094","article-title":"Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T-cell cross-priming","volume":"44","author":"Fehres","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0110","first-page":"467","article-title":"Beyond a decade of 5% imiquimod topical therapy","volume":"8","author":"Tyring","year":"2009","journal-title":"J Drugs Dermatol: JDD"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.04.028_bb0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-4632.2002.00019.x","article-title":"Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms","volume":"41","author":"Flowers","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ygyno.2016.04.028_bb0120","unstructured":"Topical 5% Imiquimod Cream for Vulvar Paget's Disease. ClinicalTrials.gov Identifier: NCT02385188. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02385188. Accessed 2\/9\/2016."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816301615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T09:36:49Z","timestamp":1620812209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816301615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0090825816301615"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}